TABLE 1.
Characteristics of COVID‐19‐positive Veterans followed in outpatient programme
| Variable | All patients (n = 120) | Tested in VA (n = 83) | Tested outside VA (n = 37) |
|---|---|---|---|
| Age categories, n (%) | |||
| <55 | 53 (44.2) | 40 (48.2) | 13 (35.1) |
| 55–65 | 25 (20.8) | 18 (21.7) | 7 (18.9) |
| 65–75 | 24 (20.0) | 17 (20.5) | 7 (18.9) |
| >75 | 18 (15.0) | 8 (9.6) | 10 (27.0) |
| Sex | |||
| Male, n (%) | 101 (84.2) | 69 (83.1) | 32 (86.5) |
| Female, n (%) | 19 (15.8) | 14 (16.9) | 5 (13.5) |
| Race | |||
| White (including Hispanic) | 88 (73.3) | 64 (77.1) | 24 (64.9) |
| Black/African American | 25 (20.8) | 13 (15.7) | 12 (32.4) |
| Unknown | 7 (5.9) | 6 (7.2) | 0 (0.0) |
| Lives Alone, n (%) | 30 (25.0) | 19 (24.4) | 11 (29.7) |
| Existing Medical Condition, n (%) | 84 (70.0) | 56 (67.5) | 28 (75.7) |
| Pulmonary disease | 26 (21.7) | 15 (18.1) | 11 (29.7) |
| Diabetes | 33 (27.5) | 22 (26.5) | 11 (29.7) |
| Cardiovascular disease | 64 (53.3) | 41 (49.4) | 23 (62.2) |
| Renal disease | 10 (8.3) | 3 (3.6) | 7 (18.9) |
| Liver disease | 10 (8.3) | 7 (8.4) | 3 (8.1) |
| Immunocompromised | 6 (5.0) | 4 (4.8) | 2 (5.4) |
| Neurologic disease | 8 (6.7) | 6 (7.2) | 2 (5.4) |
| Obesity | 32 (26.7) | 19 (22.9) | 13 (35.1) |
| Sleep apnoea | 17 (14.2) | 13 (15.7) | 4 (10.8) |
| Smoker | |||
| Current | 19 (15.8) | 12 (14.5) | 7 (18.9) |
| Former | 53 (44.2) | 38 (45.8) | 15 (40.5) |
| Severity of symptoms at initial call | |||
| None or Mild | 72 (60.0) | 47 (56.6) | 25 (67.6) |
| Moderate | 38 (31.7) | 28 (33.7) | 10 (27.0) |
| Severe | 10 (8.3) | 8 (9.6) | 2 (5.4) |
| Presenting symptoms | |||
| Cough | 76 (63.3) | 53 (63.9) | 23 (62.2) |
| Fever (overall) | 73 (60.8) | 55 (66.3) | 18 (48.6) |
| Documented | 39 (32.5) | 30 (36.1) | 9 (24.3) |
| Subjective | 34 (28.3) | 25 (30.1) | 9 (24.3) |
| Shortness of breath | 58 (48.3) | 44 (53.0) | 14 (37.8) |
| Myalgia | 58 (48.3) | 37 (44.6) | 21 (56.8) |
| Nasal congestion | 57 (47.5) | 37 (44.6) | 20 (54.1) |
| Headache | 49 (40.8) | 36 (43.4) | 13 (35.1) |
| Diarrhoea | 40 (33.3) | 27 (32.5) | 13 (35.14) |
| Chills and sweats | 37 (30.8) | 27 (32.5) | 10 (27.0) |
| Loss of taste/smell | 35 (29.2) | 23 (27.7) | 12 (32.4) |
| Chest pain | 21 (17.5) | 10 (12.1) | 10 (12.1) |
| Nausea/vomiting | 19 (15.8) | 14 (16.9) | 5 (13.5) |
| Abdominal Pain | 10 (8.3) | 5 (6.0) | 7 (18.9) |